Literature DB >> 29189922

Apathy and its impact on patient outcome in amyotrophic lateral sclerosis.

J Caga1,2, S Hsieh3, E Highton-Williamson3, M C Zoing3, E Ramsey3, E Devenney3, R M Ahmed3, M C Kiernan3,4.   

Abstract

Apathy is one of the most common behavioural symptoms of amyotrophic lateral sclerosis (ALS), yet there are few studies that have investigated the relationship between apathy and quality of life (QOL) as they are experienced by the patient. A cohort of 60 ALS patients were evaluated using the Apathy Evaluation Scale which measured cognitive, behavioural, emotional and non-specific symptoms of apathy combined with the Personal Wellbeing Index, a multidimensional measure of QOL. The relationship between patient-rated apathy and QOL scores, controlling for potential clinical and psychological confounders were analysed using univariate and multivariate methods. Apathy was identified in 30% of ALS patients. Patients with apathy reported higher levels of depression (p = 0.0001). Compared to non-apathetic patients, patients with apathy had lower overall QOL (p = 0.001), most pronounced in the domains related to achievements in life (p = 0.001) and community-connectedness (p = 0.0001). Of the cognitive, behavioural, emotional and non-specific manifestations of apathy, only the emotional symptoms explained a significant amount of variance in achievements in life (p = 0.003) and community-connectedness (p = 0.001). As such, emotional manifestations of apathy may underlie worse QOL in ALS patients presenting with behavioural impairment. Patient-reported outcomes, particularly those assessing psychosocial functioning may be important for demonstrating the efficacy of interventions designed to improve QOL in ALS patients with behavioural impairment.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Apathy; Depression; Motor neuron disease; Patient-reported outcome measures; Quality of life

Mesh:

Year:  2017        PMID: 29189922     DOI: 10.1007/s00415-017-8688-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  49 in total

1.  Right hemisphere dysfunction and emotional processing in ALS: an fMRI study.

Authors:  A Palmieri; M Naccarato; S Abrahams; M Bonato; C D'Ascenzo; S Balestreri; V Cima; G Querin; R Dal Borgo; L Barachino; C Volpato; C Semenza; E Pegoraro; C Angelini; G Sorarù
Journal:  J Neurol       Date:  2010-07-01       Impact factor: 4.849

2.  A cross sectional study on determinants of quality of life in ALS.

Authors:  A Chiò; A Gauthier; A Montuschi; A Calvo; N Di Vito; P Ghiglione; R Mutani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 3.  Health outcome and quality-of-life measurements in amyotrophic lateral sclerosis.

Authors:  M Swash
Journal:  J Neurol       Date:  1997-05       Impact factor: 4.849

4.  Dissociating apathy and depression in Parkinson disease.

Authors:  L Kirsch-Darrow; H H Fernandez; H F Fernandez; M Marsiske; M S Okun; D Bowers
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

5.  Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life.

Authors:  A Chiò; A Vignola; E Mastro; A Dei Giudici; B Iazzolino; A Calvo; C Moglia; A Montuschi
Journal:  Eur J Neurol       Date:  2010-10       Impact factor: 6.089

6.  Prevalence of depression in a 12-month consecutive sample of patients with ALS.

Authors:  P Wicks; S Abrahams; D Masi; S Hejda-Forde; P N Leigh; L H Goldstein
Journal:  Eur J Neurol       Date:  2007-09       Impact factor: 6.089

7.  Cognitive and Behavioral Symptoms in ALSFTD: Detection, Differentiation, and Progression.

Authors:  Sharpley Hsieh; Jashelle Caga; Felicity V C Leslie; Marlene Shibata; Naomi Daveson; David Foxe; Eleanor Ramsey; Patricia Lillo; Rebekah M Ahmed; Emma Devenney; James R Burrell; John R Hodges; Matthew C Kiernan; Eneida Mioshi
Journal:  J Geriatr Psychiatry Neurol       Date:  2015-08-06       Impact factor: 2.680

Review 8.  Social cognition in neurodegenerative disorders: a systematic review.

Authors:  Marwa Elamin; Niall Pender; Orla Hardiman; S Abrahams
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-08-06       Impact factor: 10.154

Review 9.  Apathy: a neuropsychiatric syndrome.

Authors:  R S Marin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1991       Impact factor: 2.198

10.  Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

Authors:  Michael J Strong; Gloria M Grace; Morris Freedman; Cathy Lomen-Hoerth; Susan Woolley; Laura H Goldstein; Jennifer Murphy; Christen Shoesmith; Jeffery Rosenfeld; P Nigel Leigh; Lucie Bruijn; Paul Ince; Denise Figlewicz
Journal:  Amyotroph Lateral Scler       Date:  2009-06
View more
  5 in total

Review 1.  Cognitive dysfunction in amyotrophic lateral sclerosis: can we predict it?

Authors:  Fabiola De Marchi; Claudia Carrarini; Antonio De Martino; Luca Diamanti; Antonio Fasano; Antonino Lupica; Mirella Russo; Simone Salemme; Edoardo Gioele Spinelli; Alessandro Bombaci
Journal:  Neurol Sci       Date:  2021-03-27       Impact factor: 3.307

2.  Factors That Influence Non-Motor Impairment Across the ALS-FTD Spectrum: Impact of Phenotype, Sex, Age, Onset and Disease Stage.

Authors:  Emma M Devenney; Kate McErlean; Nga Yan Tse; Jashelle Caga; Thanuja Dharmadasa; William Huynh; Colin J Mahoney; Margaret Zoing; Srestha Mazumder; Carol Dobson-Stone; John B Kwok; Glenda M Halliday; John R Hodges; Olivier Piguet; Rebekah M Ahmed; Matthew C Kiernan
Journal:  Front Neurol       Date:  2021-11-25       Impact factor: 4.003

Review 3.  Oxytocin in Huntington's disease and the spectrum of amyotrophic lateral sclerosis-frontotemporal dementia.

Authors:  Sofia Bergh; Rachel Y Cheong; Åsa Petersén; Sanaz Gabery
Journal:  Front Mol Neurosci       Date:  2022-09-14       Impact factor: 6.261

Review 4.  Cognitive and Behavioral Manifestations in ALS: Beyond Motor System Involvement.

Authors:  Robert Rusina; Rik Vandenberghe; Rose Bruffaerts
Journal:  Diagnostics (Basel)       Date:  2021-03-30

Review 5.  A systematic review of neuropsychiatric and cognitive assessments used in clinical trials for amyotrophic lateral sclerosis.

Authors:  Emily Beswick; Emily Park; Charis Wong; Arpan R Mehta; Rachel Dakin; Siddharthan Chandran; Judith Newton; Alan Carson; Sharon Abrahams; Suvankar Pal
Journal:  J Neurol       Date:  2020-09-10       Impact factor: 6.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.